Treatment of Community-Acquired Pneumonia During the Coronavirus Disease 2019 (COVID-19) Pandemic.
editorial · Level V
Where this comes from
- Record sourced from PubMed, PMID 32379883.
- Also identified by DOI 10.7326/M20-2189 and PMC identifier 7236892.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Although pneumonia caused by severe acute respiratory syndrome coronavirus 2 is a prominent feature of COVID-19, clinicians must consider whether treatment for additional potential causes of community-acquired pneumonia (CAP) is appropriate. The cochairs of the recently released American Thoracic Society and Infectious Diseases Society of America Guideline for Treatment of Adults with CAP offer their interpretation of this guideline's application to the evaluation and treatment of patients with COVID-19.
Medical subject headings
- Coinfection
- Community-Acquired Infections
- Coronavirus Infections
- Pneumonia
- Pneumonia, Viral